ZEPP Stock Forecast 2025-2026
Distance to ZEPP Price Targets
ZEPP Price Momentum
10 Quality Stocks Worth Considering Now
Researching Zepp Health (ZEPP) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on ZEPP and similar high-potential opportunities.
Latest ZEPP Stock Price Targets & Analyst Predictions
Wall Street analysts covering ZEPP have a bullish consensus with a median price target of $14.65 (ranging from $14.65 to $14.65). Currently trading at $3.06, the median forecast implies a 378.8% upside. This outlook is supported by 1 Buy, 0 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ZEPP Analyst Ratings
ZEPP Price Target Range
Latest ZEPP Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ZEPP.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Zepp Health Corporation (ZEPP) Competitors
The following stocks are similar to Zepp Health based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Zepp Health Corporation (ZEPP) Financial Data
Zepp Health Corporation has a market capitalization of $44.75M with a P/E ratio of -1.6x. The company generates $208.95M in trailing twelve-month revenue with a -18.8% profit margin.
Revenue growth is -48.9% quarter-over-quarter, while maintaining an operating margin of -29.5% and return on equity of -11.9%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Zepp Health Corporation (ZEPP) Business Model
About Zepp Health Corporation
Develops smart wearable health technology devices.
Zepp Health Corporation generates revenue by designing and manufacturing advanced smartwatches and fitness trackers that incorporate biosensors for monitoring various health metrics. The company's products appeal to health-conscious consumers, enabling them to track their wellness and activity levels effectively.
The growing demand for wearable technology, driven by increased consumer awareness of health and wellness, positions Zepp Health favorably in the market. Their strong emphasis on research and development ensures that they remain competitive and innovative within the health technology sector.
Company Information
Sector
Technology
Industry
Consumer Electronics
Employees
839
CEO
Mr. Wang Huang
Country
China
IPO Year
2018
Website
www.huami.comZepp Health Corporation (ZEPP) Latest News & Analysis
Gabby Thomas, a five-time Olympic medalist, has been appointed as an athlete ambassador for Amazfit, a brand known for its fitness technology products.
Gabby Thomas joining Amazfit enhances brand visibility and credibility, potentially boosting sales and attracting new customers, which can positively impact the company’s stock performance.
The global luxury smart jewelry market is projected to reach $429.97 million by 2030, with a CAGR of 18.9% from 2025 to 2030, according to a new report from ResearchAndMarkets.com.
The projected growth of the luxury smart jewelry market to nearly $430 million by 2030 indicates strong demand and investment potential in a high-margin sector.
Amazfit Announces the Active 2; the Ultimate Everyday Smartwatch for Active and Healthy Living
2 months agoAmazfit, owned by Zepp Health (NYSE: ZEPP), has launched the Amazfit Active 2 smartwatch, combining style and functionality, as of January 6, 2025.
The launch of the Amazfit Active 2 could drive sales growth for Zepp Health, potentially boosting stock performance and market share in the competitive wearables sector.
Zepp Health (NYSE: ZEPP) launched a "Try Before You Buy" program for its smart hearing solutions brand, Zepp Clarity, at CES 2025 in Las Vegas.
Zepp Health's "Try Before You Buy" program could boost sales and customer engagement, enhancing brand loyalty and market share in the competitive health tech sector.
Zepp Health to Showcase Groundbreaking Innovations at CES Pepcom & ShowStoppers Media Events
2 months agoZepp Health Corporation (NYSE: ZEPP) will showcase its latest smart wearables and health technology at CES 2023 events, aiming to promote healthier lifestyles through innovation.
Zepp Health's participation in major events like CES highlights its innovation in health tech, potentially driving demand and enhancing investor confidence in its growth prospects.
Zepp Health Corporation (NYSE: ZEPP) will hold its Q3 2024 earnings conference call on November 18, 2024, at 8:30 PM ET, featuring key executives and analysts.
Zepp Health's Q3 2024 results could reveal financial health and growth potential, influencing stock performance and investor sentiment. Key executives will provide insights during the call.
Frequently Asked Questions About ZEPP Stock
What is Zepp Health Corporation's (ZEPP) stock forecast for 2025?
Based on our analysis of 0 Wall Street analysts, Zepp Health Corporation (ZEPP) has a median price target of $14.65. The highest price target is $14.65 and the lowest is $14.65.
Is ZEPP stock a good investment in 2025?
According to current analyst ratings, ZEPP has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $3.06. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ZEPP stock?
Wall Street analysts predict ZEPP stock could reach $14.65 in the next 12 months. This represents a 378.8% increase from the current price of $3.06. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Zepp Health Corporation's business model?
Zepp Health Corporation generates revenue by designing and manufacturing advanced smartwatches and fitness trackers that incorporate biosensors for monitoring various health metrics. The company's products appeal to health-conscious consumers, enabling them to track their wellness and activity levels effectively.
What is the highest forecasted price for ZEPP Zepp Health Corporation?
The highest price target for ZEPP is $14.65 from at , which represents a 378.8% increase from the current price of $3.06.
What is the lowest forecasted price for ZEPP Zepp Health Corporation?
The lowest price target for ZEPP is $14.65 from at , which represents a 378.8% increase from the current price of $3.06.
What is the overall ZEPP consensus from analysts for Zepp Health Corporation?
The overall analyst consensus for ZEPP is bullish. Out of 0 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $14.65.
How accurate are ZEPP stock price projections?
Stock price projections, including those for Zepp Health Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
